New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
Copa Holdings (CPA) upgraded to Buy from Neutral at UBS... Cross Country Healthcare (CCRN) upgraded to Buy from Neutral at Citigroup... GT Advanced (GTAT) upgraded to Outperform from Neutral at Credit Suisse... Omnicare (OCR) upgraded to Buy from Neutral at UBS... Polycom (PLCM) upgraded to Buy from Neutral at Citigroup... Quality Systems (QSII) upgraded to Market Perform from Underperform at FBR Capital... Safeway (SWY) upgraded to Neutral from Sell at UBS... Skullcandy (SKUL) upgraded to Outperform from Market Perform at Northland Securities... Teva (TEVA) upgraded to Overweight from Equal Weight at Barclays... The Buckle (BKE) upgraded to Neutral from Sell at Janney Capital... The Fresh Market (TFM) upgraded to Buy from Neutral at UBS... Union Pacific (UNP) upgraded to Outperform from Market Perform at Avondale... Bridgepoint Education (BPI) upgraded to Outperform at William Blair... Bank of Montreal (BMO) upgraded to Sector Performer from Underperformer at CIBC... SandRidge Energy (SD) upgraded to Overweight at Stephens citing turnaround progress... Haemonetics (HAE) upgraded to Buy from Neutral at Sidoti... Charter (CHTR) upgraded at Northland Securities... Prudential (PRU) upgraded to Buy from Neutral at BofA/Merrill... United Community Banks (UCBI) upgraded to Buy from Hold at Sandler O'Neill... Sirius XM (SIRI) upgraded at Macquarie... Clean Harbors (CLH) upgraded at Raymond James... Cabot Oil & Gas (COG) upgraded to Buy from Accumulate at KLR Group... Ivanhoe Mines (IVN) upgraded to Buy from Neutral at UBS.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
March 23, 2015
13:13 EDTUNPRailroad operators trade lower after Kansas City Southern reduces FY15 guidance
Subscribe for More Information
12:17 EDTUNPOn The Fly: Midday Wrap
Subscribe for More Information
12:10 EDTTEVATeva migraine drug data positive for Amgen, says Piper Jaffray
Piper Jaffray said the "positive" trial data Teva (TEVA) reported for its anti-CGRP antibody in migraines is another important validation for the class of drugs that is also being worked on by Amgen (AMGN), Eli Lilly (LLY) and Alder Biopharmaceuticals (ALDR). The firm said it thinks Amgen is one of the leaders in CGRP antibody space and reiterated its Overweight rating and $187 price target on Amgen shares.
09:43 EDTBPIBridgepoint Education management to meet with Barrington
Subscribe for More Information
08:50 EDTTEVATeva reports TEV-48125 met endpoints in phase 2b study
Subscribe for More Information
08:13 EDTCPABofA/Merrill airlines/aerospace analysts hold analyst/industry conference call
Subscribe for More Information
March 20, 2015
16:22 EDTQSIIQuality Systems CFO Paul Holt resigns, John Stumpf named as interim CFO
On March 18, Paul Holt informed the board the he will resign as CFO of the company, effective April 12. Holt has served the company for over 15 years and is leaving to join NantHealth as its CFO. On March 19, the board appointed John Stumpf as the company's interim CFO, effective immediately upon Holt's departure from the company.
09:59 EDTCHTRCharter may have interest in Cablevision 'at some point,' says Detwiler
Detwiler Fenton believes there is truth to last week's reports of Charter (CHTR) being in talks to acquire Bright House Networks. In addition, the firm says its checks indicate Charter may have interest in buying Suddenlink Communications and Cablevision (CVC) "at some point" as a part of a lager acquisition strategy. Detwiler adds Charter's potential deal strategy assumes Comcast's (CMCSA) bid for Time Warner (TWC) wins regulatory approval. Should the deal not get approved, Detwiler believes Charter will turn its attention back to Time Warner.
07:10 EDTUNPUnion Pacific weakness a buying opportunity, says UBS
Subscribe for More Information
March 19, 2015
10:02 EDTQSIIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:32 EDTBPIBridgepoint Education appoints Christopher Henn as COO
Bridgepoint Education's board announced the selection of Christopher Henn who, beginning April 13, will serve in the company's newly created role of Executive Vice President and COO. Most recently, Henn served as Managing Director Product for Esurance.
March 18, 2015
16:13 EDTTEVAFibrocell Science appoints Keith Goldan as CFO
Fibrocell Science announced the appointment of Keith Goldan as senior VP and Chief Financial Officer, effective immediately. Prior to joining Fibrocell, Goldan served as CFO of two publicly traded companies. Most recently he served as SVP and CFO of NuPathe, which was acquired by Teva Pharmaceutical (TEVA) in 2014.
16:07 EDTQSIIQuality Systems downgraded to Neutral from Outperform at RW Baird
Subscribe for More Information
13:13 EDTCOGAnalyst recommends buying top E&P names before crude finds its bottom
Subscribe for More Information
11:36 EDTTEVAIgnyta price target raised to $17 from $14 at Leerink
Subscribe for More Information
10:08 EDTTEVAEagle Pharmaceuticals price target increased to $67 from $43 at William Blair
William Blair raised its price target on Eagle Pharmaceuticals to $67 from $43 citing its belief that the company can become profitable and have significant cash flow pending the approval of EP-3102. The company added that it view last week's FDA label change for Teva's (TEVA) Treanda as a positive for EP-3102 and that its new price target assumes 2016 launch and "reasonable" penetration for EP-3102.
10:01 EDTPLCMPolycom and Microsoft announces new series of video collaboration solutions
Subscribe for More Information
09:02 EDTPRUEl Paso enters three-year contract with Prudential
Prudential Retirement announced the City of El Paso has recommitted its defined contribution plan to Prudential Retirement. Prudential Retirement is a business unit of Prudential Financial. The city has entered a three-year contract with the company.
07:21 EDTCOGE&P stocks should be bought on weakness, says Stifel
Subscribe for More Information
07:13 EDTTEVATeva volatility elevated, shares near four year high
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use